Each cellular component of the liver (e.g., hepatocyte, biliary, endothelial, or other mesenchymal cells) can undergo benign proliferation, but only four lesions have common clinical relevance ...
For solid lesions, HCC, fibrolamellar carcinoma ... or operative resection should be considered. Male sex and benign liver tumor: an a priori suspicious combination. The major risk of a benign ...
Artificial Intelligence (AI) can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records, finds a study.